Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization.

Joon Sig Choi1, J Andrew MacKay, Francis C Szoka

  • 1Department of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California at San Francisco, 94143-0446, USA.

Bioconjugate Chemistry
|March 20, 2003
PubMed
Summary

New pH-sensitive plasmid-lipid nanoparticles (POD SPLP) demonstrate enhanced gene transfer efficiency. These nanoparticles utilize an acid-labile lipid for triggered endosomal escape, significantly improving in vitro gene delivery compared to pH-insensitive controls.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and biochemical analyses of a novel bacterial dual specificity phosphatase from Candidatus Chlorohelix allophototropha.

Journal of microbiology (Seoul, Korea)·2026
Same author

Crystal structure of Bcl-2 from lymphocystis disease virus 2 in complex with the BH3 domain of zebrafish BaxA.

Journal of microbiology (Seoul, Korea)·2026
Same author

Dynamic progression of ectopic lymphoid structure formation in lacrimal glands of a Sjögren's disease murine model.

Frontiers in immunology·2026
Same author

AI-validated fusion proteins for local inhibition of interleukin-17A.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Mitochondrial DNA Variation in the Aging Human Cerebral Cortex and Cerebellum.

Aging cell·2025
Same author

Crystal structures of the μ2 subunit of clathrin-adaptor protein 2 in complex with peptides derived from human papillomavirus 16 E7.

Journal of microbiology (Seoul, Korea)·2025

Area of Science:

  • Nanomedicine
  • Biotechnology
  • Gene Therapy

Background:

  • Developing effective non-viral gene delivery vectors is crucial for gene therapy.
  • Lipid nanoparticles are promising carriers, but efficient endosomal escape remains a challenge.
  • pH-sensitive components can facilitate endosomal release.

Purpose of the Study:

  • To develop and characterize novel pH-sensitive stabilized plasmid-lipid nanoparticles (POD SPLP).
  • To evaluate the gene transfer efficiency of POD SPLP in vitro.
  • To elucidate the mechanism of enhanced gene delivery mediated by POD SPLP.

Main Methods:

  • Preparation of POD SPLP using detergent dialysis with an acid-labile lipid (poly(ethyleneglycol)-diorthoester-distearoylglycerol lipid) and a cationic lipid-phosphatidylethanolamine mixture.

Related Experiment Videos

  • Characterization of nanoparticle size, zeta potential, and DNA encapsulation efficiency.
  • Assessment of pH-triggered nanoparticle collapse and in vitro gene transfer activity.
  • Comparison with nanoparticles prepared using a pH-insensitive PEG-lipid.
  • Main Results:

    • POD SPLP nanoparticles (60 nm) were successfully prepared with optimal DNA encapsulation at specific lipid ratios.
    • POD SPLP exhibited pH-sensitive collapse at acidic pH (5.3), unlike pH-insensitive controls.
    • POD SPLP demonstrated up to 3 orders of magnitude greater gene transfer activity than pH-insensitive nanoparticles.
    • Enhanced gene transfer was attributed to faster endosomal escape, not increased cellular association.

    Conclusions:

    • The pH-sensitive POD SPLP effectively mediates enhanced gene transfer in vitro.
    • The acid-labile nature of the POD lipid facilitates triggered endosomal escape.
    • POD SPLP represents a promising synthetic vector for parenteral gene therapy applications.